Perhaps the most notable inclusions so far this year involve Novo Nordisks Ozempic and Eli Lillys Mounjaro, the latest in a class of drugs called incretins, named after the group of hormones that they mimic
This weight-loss benefit does not apply to Mounjaro, which is diabetes-only
They come from a handful of companies and consist of many ingredients similar to those you might find in a testosterone-targeted supplement
Following a 12-week low FODMAP diet intake, the participants exhibited a significant induction in circulating GLP-1 levels (increasing modestly from about 3.3 pM to 3.6 pM), significantly reduced body weight, and significantly improved IBS and gastrointestinal symptoms
We review: Medical history Current medications Cardiovascular risk factors Personal weight history Lifestyle patterns Labs may include: Fasting glucose Hemoglobin A1C Insulin Lipid panel Thyroid panel Hormone evaluation when indicated Semaglutide is not prescribed without appropriate screening
Sign up for a free IBS mini course here